Pharma CEO Martin Shkreli says a new price for the drug he hiked could be here by Christmas - but it'll only be a 'modest' decrease
A New York Times article reported that a price decrease for Daraprim would be on the order of 10%. But Shkreli told Business Insider that that number was taken out of context.
He had said there would be a modest decrease, and was then asked what "modest" would be for him. That, he said, is where the 10% came in, but there's no decision just yet.
"We'll announce when we announce," he said.
He added that the announcement will come by December 25, though he added that he's not constantly thinking about it.
Shkreli also added that Valeant Pharmaceuticals and other companies that practice what Democratic presidential candidate Hillary Clinton and others have labeled "price gouging" still haven't lowered the prices on any of their drugs.
"Nobody's lowered their prices ... why should I?" he said.
As for when he's going to answer demands from the houses of Congress to answer for his controversial practices, Shkreli said he's not convinced he'll have to.
"When my lawyers tell me I absolutely have to go, I'll go," he said. "They don't have subpoena power until they've got widespread support. I don't have to go to a hearing unless there's widespread support."
- Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says.
- I spent $2,000 for 7 nights in a 179-square-foot room on one of the world's largest cruise ships. Take a look inside my cabin.
- An Ambani disruption in OTT: At just ₹1 per day, you can now enjoy ad-free content on JioCinema
- Realme C65 5G with 5,000mAh battery, 120Hz display launched starting at ₹10,499
- 8 Fun things to do in Kasol
- SC rejects pleas seeking cross-verification of votes cast using EVMs with VVPAT
- Ultraviolette F77 Mach 2 electric sports bike launched in India starting at ₹2.99 lakh
- Deloitte projects India's FY25 GDP growth at 6.6%
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market